MedTrace Logo

Cross-sectional Study to Characterize Real World Burden of Disease in Patients With Vitiligo in China

NCT07058051 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2025-11-19

No results posted yet for this study

Summary

The purpose of this study is to evaluate the patterns of treatment, healthcare resources utilized and the burdens associated with non-segmental vitiligo (NSV) amongst participants in China

This study is a cross-sectional, multicenter, observational study of vitiligo patients in China. The cross-sectional design is sufficient to characterize the overall current burden of NSV.

Conditions

  • Non-Segmental Vitiligo

Sponsors & Collaborators

Principal Investigators

  • ABBVIE INC. · AbbVie

Eligibility

Min Age
12 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-07-17
Primary Completion
2025-11-13
Completion
2025-11-13

Countries

  • China

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07058051 on ClinicalTrials.gov